Genistein supplementation and estrogen replacement therapy improve endothelial dysfunction induced by ovariectomy in rats

Cardiovascular Research

Volumn 45, Issue 2, 2000, Pages 454-462

  Squadrito, Francesco ^a   Altavilla, Domenica ^a   Squadrito, Giovanni ^a   Saitta, Antonino ^a   Cucinotta, Domenico ^a   Minutoli, Letteria ^a   Deodato, Barbara ^a   Ferlito, Marcella ^a   Campo, Giuseppe M ^a   Bova, Antonio ^a   Caputi, Achile P ^a  

^a UNIVERSITY OF MESSINA   (Italy)

Author keywords

Endothelial function; Hormones; Nitric oxide

Indexed keywords

ACETYLCHOLINE; ESTRADIOL; GENISTEIN; N(G) NITROARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE SODIUM; PHYTOESTROGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL REACTIVITY; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM LESION; ENZYME ACTIVITY; ESTROGEN THERAPY; FEMALE; HEART RATE; MEAN ARTERIAL PRESSURE; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; RAT; VASODILATATION;

ACETYLCHOLINE; ANIMALS; AORTA; BLOOD PRESSURE; CHOLESTEROL; ENDOTHELIUM, VASCULAR; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; GENISTEIN; HEART RATE; LUNG; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; ORGAN SIZE; OVARIECTOMY; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; UTERUS; VASODILATOR AGENTS;

EID: 0033979106     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(99)00359-4     Document Type: Article

References (37)

1. Barret-Connor H., Bush R.L. Estrogen and coronary heart disease in women. J Am Med Assoc. 265:1991;1861-1867.
2. Grady D., Rubin S.M., Pettiti D.B., et al. Hormone therapy to prevent diseases and prolong life in postmenopausal women. Ann Intern Med. 117:1992;549-556.
3. Lip G.Y., Blann A.D., Jones A.F., Beevers D.G. Effects of hormone-replacement therapy on hemostatic factors, lipid factors, and endothelial function in women undergoing surgical menopause: implications for prevention of atherosclerosis. Am Heart J. 134:1997;764-771.
4. Kleinert H., Wallerath T., Euchenhofer C., Ihrig-Biedert I., Li H., Forstermann U. Estrogens increase transcription of the human endothelial NO synthase gene: analysis of the transcription factors involved. Hypertension. 31:1998;582-584.
5. Gerhard M., Walsh B.W., Tawakol A., et al. Estradiol therapy combined with progesterone and endothelium-dependent vasodilation in postmenopausal women. Circulation. 12:1998;1158-1163.
6. Grady D., Gebretsadik T., Kerlikowske K., Ernster V., Pettiti D. Hormone replacement therapy and endometrial cancer risk: a meta-analysis. Obstet Gynecol. 85:1995;304-313.
7. Robinson R.W., Higano N., Cohen W.D. Long-term effects of high dosage estrogen therapy in men with coronary heart disease. J. Chron Dis. 16:1963;155-161.
8. Washburn S.A., Adams M.R., Clarkson T.B., Adelman S.J. A conjugated equine estrogen with differential effects on uterine weight and plasma cholesterol in the rat. Am J Obstet Gynecol. 169:1993;251-256.
9. Washburn S.A., Honorè E.K., Cline J.M., et al. Effects of 17α-dihydroequilenin sulfate on atherosclerotic male and female rhesus monkey. Am J Obstet Gynecol. 175:1996;341-351.
10. Anthony M.S., Clarkson T.B., Hughes C.L., Morgan T.M., Burke G.L. Soybean isoflavones, improve cardiovascular risk factors without affecting the reproductive system of peripubertal rhesus monkeys. J Nutr. 126:1996;43-50.
11. Black L.J., Sato M., Rowley E.R., et al. Raloxifene (LY139481 HCL) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats. J Clin Invest. 93:1994;63-69.
12. Ke H.Z., Simmons H.A., Pirie C.M., Crawford D., Thompson D.D. Droloxifene, a new estrogen agonist/antagonist, prevents bone loss in ovariectomized rats. Endocrinology. 136:1995;2435-2441.
13. Honore E.K., Williams J.K., Anthony M.S., Clarkson T.B. Soy isoflavones enhance coronary vascular reactivity in atherosclerotic female macaques. Fertil Steril. 67:1997;148-154.
14. Supko J.G., Phillips L.R. High-performance liquid chromatographic assay for genistein in biological fluids. J Chromatogr B Biomed Appl. 666:1995;157-167.
15. Bredt D.S., Snyder S.H. Isolation of nitric oxide synthase, a calmodulin-requiring enzyme. Proc Natl Acad Sci USA. 87:1990;682-685.
16. Bradford M.M. A rapid and sensitive method for the quantification of protein dye binding. J Biol Chem. 72:1976;700-703.
17. Adlercreutz H., Markkanen H., Watanabe S. Plasma concentrations of phytoestrogens in Japanese men. Lancet. 342:1993;1209-1210.
18. Barnes S., Grubbs C., Setchell K.D.R., Carlson J. Soybeans inhibit mammary tumors in models of breast cancer. Prog Clin Biol Res. 347:1990;239-253.
19. Setchell K.D.R., Borriello S.P., Hulme P., Kirk D.N., Axelson M. Nonsteroidal estrogens of dietary origin: Possible roles in hormone-dependent disease. Am J Clin Nutr. 40:1984;569-578.
20. Makela S., Davis V.L., Tally W.C., et al. Dietary estrogens act through estrogen receptor-mediated processes and show no antiestrogenicity in cultured breast cancer cells. Environ Health Perspect. 102:1994;572-578.
21. Akyama T., Ishida J., Nakagawa S., et al. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem. 262:1987;5592-5595.
22. Messina M., Barnes S. The role of soy products in reducing risk of cancer. J Natl Cancer Inst. 83:1991;541-546.
23. Eldridge A.C. Determination of isoflavones in soybean flours protein concentration and isolate. J Agric Food Sci. 30:1982;353-355.
24. Martin P.M., Horwitz K.B., Ryan D.S., McGuire W.L. Phytoestrogen interaction with estrogen receptors in human breast cancer cells. Endocrinology. 103:1978;1860-1867.
25. Williams J.K., Adams M.R., Klopfenstein H.S. Estrogen modulates responses of atherosclerotic coronary arteries. Circulation. 81:1990;1680-1687.
26. Gilligan D.M., Quyyumi A.A., Cannon III R.O. Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women. Circulation. 89:1994;2545-2551.
27. Lieberman E.H., Gerhard M.D., Uehata A., Walsh B.W., Selwyn A.P., Ganz P. Estrogen improves endothelium-dependent, flow mediated vasodilation in postmenopausal women. Ann Intern Med. 121:1994;936-941.
28. Luscher T.F., Dbey R.K. Endothelium and platelet-derived vasoactive substances: role in the regulation of vascular tone and growth. Laragh J.H., Brenner B.M. 2nd ed Hypertension: pathophysiology, diagnosis and management. 1994;609-630 Raven Press, New York.
29. Furchgott R.F., Zawadzki J.V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acethylcholine. Nature. 288:1980;373-376.
30. Ignarro L.J., Byrns R.E., Buga G.M., Wood K.S. Endothelium-derived relaxing factor from pulmonary and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical. Circ Res. 61:1987;866-879.
31. Mellion B.T., Ignarro L.J., Ohlstein E.H., Pontecorvo E.G., Hyman A.L., Kadowitz P.J. Evidence for the inhibitory role of guanosine 3′5′-monophoshate in ADP-induced human platelet aggregation in the presence of nitric oxide and related vasodilators. Blood. 57:1981;946-955.
32. Dubey R.K. Vasodilator-derived nitric oxide inhibits angiotensin-II and fetal calf serum induced growth of arteriolar smooth muscle cells. J Pharmacol Exp Ther. 269:1994;402-408.
33. Reis S.E., Gloth S.T., Blumenthal R.S., et al. Ethynyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women. Circulation. 89:1994;52-60.
34. Potter S.M. Soy protein and cardiovascular disease: the impact of bioactive components in soy. Nutr Rev. 56:1998;231-235.
35. Nevala R., Korpela R., Vapaatalo H. Plant derived estrogens relax rat mesenteric artery in vitro. Life Sci. 63:1998;95-100.
36. Losordo D.W., Kearney M., Kim E.A., Jekanowski J., Isner J.M. Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of postmenopausal women. Circulation. 89:1994;1501-1510.
37. Stahl S., Chun T., Gray W.G. Phytoestrogens act as estrogen agonists in a estrogen-responsive pituitary cell line. Toxicol Appl Pharmacol. 152:1998;41-48.